Global Decentralised Clinical Trials Market Report 2026-2036 | Market to Reach US$33.5bn at 11.5% CAGR as AI, Remote Monitoring and Hybrid Models Transform Drug Development
Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Decentralised Clinical Trials Market Report 2026-2036" has been added to ResearchAndMarkets.com's offering.
The global decentralised clinical trials market is projected to grow from US$11.3bn in 2026 to US$33.5bn by 2036, at a CAGR of 11.5%. This near-tripling in market value reflects the expanding role of decentralised and hybrid models in mainstream clinical development.
Market growth is being driven by advances in digital health technology, increased adoption of patient-centric trial designs, and wider use of remote monitoring and real-time data capture. These capabilities can improve participant engagement, strengthen data quality, and increase operational efficiency. AI and advanced analytics are also enabling predictive monitoring, adaptive trial design, and faster decision-making across clinical programmes.
Trade, Policy and Supply Chain Dynamics
Global trade conditions, regulatory changes, and geopolitical developments are influencing the deployment and cost of decentralised clinical trial technologies. The market depends on connected medical devices, sensors, wearable devices, and digital infrastructure - creating exposure to tariffs, export controls, component availability, and regional regulatory differences.
Competitive Landscape and Company Intelligence
The decentralised clinical trials market includes established technology vendors, clinical research organisations, and specialist digital health platforms. Medable, Science 37, IQVIA, Parexel, and other leading companies are expanding their capabilities through platform development, strategic partnerships, and investment in hybrid and fully decentralised trial models.
Competitive differentiation is increasingly based on technology integration, data compliance, global operational reach, scalability, and support for patient-centric study designs. Emerging providers are also gaining traction by offering flexible platforms, digital agility, specialist expertise, and cost advantages.
The report evaluates market positioning and strategic developments among 4G Clinical, Advarra Inc., Clario, ICON PLC, IQVIA Inc., Medable, Inc., Oracle Corporation, Parexel International Corporation, Science 37, and Veeva Systems. Company profiles assess business operations, financial and market positioning, product and technology capabilities, and strategic outlook.
Report Scope and Market Segmentation
This decentralised clinical trials market report combines quantitative revenue forecasting with strategic analysis of technology, competition, regulation, policy, and supply chain conditions. It provides global, regional, and national forecasts through 2036, supported by segment-level modelling.
Geographic Market Coverage
Key Questions Addressed
Bespoke Intelligence and Customisation
Visiongain provides tailored market intelligence and advisory support for organisations requiring analysis aligned with specific commercial, operational, or investment priorities. Available services include custom market segmentation and forecasting, competitive benchmarking, policy and regulatory impact assessment, supply chain and sourcing intelligence, and scenario modelling covering tariffs and geopolitical risk.
Strategic Value of the Report
Digital transformation, regulatory evolution, and changing clinical development models are reshaping the decentralised clinical trials market. This report enables pharmaceutical companies, biopharmaceutical companies, clinical research organisations, technology providers, investors, and other stakeholders to identify growth opportunities, assess competitive threats, manage regulatory and supply chain risk, and support evidence-based strategic planning through 2036.
Key Attributes:
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/irx106
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.